Cefprozil
Alternative Names: BMY-28100; BMY-28167; Brisoral; Cefzil; Cronocef; ProcefLatest Information Update: 05 Nov 2023
At a glance
- Originator Bristol-Myers Squibb
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bacterial infections; Respiratory tract infections; Skin and soft tissue infections
Most Recent Events
- 13 Feb 2013 Cefprozil sublicensed to Swedish Orphan Biovitrum in Austria, Belgium, Ireland, United Kingdom, France, Italy Germany, Spain, Finland, Sweden, Denmark, Norway, Liechtenstein, Netherlands, Portugal, and Luxembourg
- 31 Dec 2012 Cefprozil licensed to PharmaSwiss in Europe
- 23 Jul 2008 Bentley Pharmaceuticals has been acquired by Teva Pharmaceutical Industries